Morri E Feldman
Overview
Explore the profile of Morri E Feldman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herbert S, Huisken J, Kim T, Feldman M, Houseman B, Wang R, et al.
Science
. 2009 Oct;
326(5950):294-8.
PMID: 19815777
Blood vessels form de novo (vasculogenesis) or upon sprouting of capillaries from preexisting vessels (angiogenesis). With high-resolution imaging of zebrafish vascular development, we uncovered a third mode of blood vessel...
2.
Apsel B, Blair J, Gonzalez B, Nazif T, Feldman M, Aizenstein B, et al.
Nat Chem Biol
. 2008 Oct;
4(11):691-9.
PMID: 18849971
The clinical success of multitargeted kinase inhibitors has stimulated efforts to identify promiscuous drugs with optimal selectivity profiles. It remains unclear to what extent such drugs can be rationally designed,...
3.
Knight Z, Feldman M, Balla A, Balla T, Shokat K
Nat Protoc
. 2007 Oct;
2(10):2459-66.
PMID: 17947987
Phosphoinositide kinases such as PI3-kinase synthesize lipid second messengers that control diverse cellular processes. Recently, these enzymes have emerged as an important class of drug targets, and there is significant...
4.
Knight Z, Gonzalez B, Feldman M, Zunder E, Goldenberg D, Williams O, et al.
Cell
. 2006 May;
125(4):733-47.
PMID: 16647110
Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined. We describe here an approach to pharmacologically interrogate the...